These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24330520)

  • 21. The effects of gender-affirming hormone therapy and mastectomy on psychopathology, body image, and quality of life in adults with gender dysphoria who were assigned female at birth.
    Turan Ş; Özulucan MT; Karataş U; Kavla Y; Koyuncu O; Durcan E; Durcan G; Bağhaki S
    Qual Life Res; 2024 Jul; 33(7):1937-1947. PubMed ID: 38656406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sociodemographic Study of Danish Individuals Diagnosed with Transsexualism.
    Simonsen R; Hald GM; Giraldi A; Kristensen E
    Sex Med; 2015 Jun; 3(2):109-17. PubMed ID: 26185676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgender Surgery in Denmark From 1994 to 2015: 20-Year Follow-Up Study.
    Aydin D; Buk LJ; Partoft S; Bonde C; Thomsen MV; Tos T
    J Sex Med; 2016 Apr; 13(4):720-5. PubMed ID: 26928773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood maltreatment in subjects with male-to-female gender identity disorder.
    Bandini E; Fisher AD; Ricca V; Ristori J; Meriggiola MC; Jannini EA; Manieri C; Corona G; Monami M; Fanni E; Galleni A; Forti G; Mannucci E; Maggi M
    Int J Impot Res; 2011; 23(6):276-85. PubMed ID: 21833007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style.
    Colizzi M; Costa R; Pace V; Todarello O
    J Sex Med; 2013 Dec; 10(12):3049-58. PubMed ID: 23574768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopathological symptoms in Spanish subjects with gender dysphoria. A cross-sectional study.
    Castelo-Branco C; RiberaTorres L; Gómez-Gil E; Uribe C; Cañizares S
    Gynecol Endocrinol; 2021 Jun; 37(6):534-540. PubMed ID: 33904350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a transgender population in Portugal.
    Ferreira MJ; Castedo JL; Mota M; Carvalho D
    Ann Endocrinol (Paris); 2022 Feb; 83(1):35-39. PubMed ID: 34871600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affective temperaments in subjects with female-to-male gender dysphoria.
    Turan Ş; Poyraz CA; Öcek Baş T; Kani AS; Duran A
    J Affect Disord; 2015 May; 176():61-4. PubMed ID: 25702601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment.
    Aranda G; Fernández-Rebollo E; Pradas-Juni M; Hanzu FA; Kalko SG; Halperin I; Mora M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():20-28. PubMed ID: 28539237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS).
    Schneider F; Neuhaus N; Wistuba J; Zitzmann M; Heß J; Mahler D; van Ahlen H; Schlatt S; Kliesch S
    J Sex Med; 2015 Nov; 12(11):2190-200. PubMed ID: 26559385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychological characteristics of Italian gender dysphoric adolescents: a case-control study.
    Fisher AD; Ristori J; Castellini G; Sensi C; Cassioli E; Prunas A; Mosconi M; Vitelli R; Dèttore D; Ricca V; Maggi M
    J Endocrinol Invest; 2017 Sep; 40(9):953-965. PubMed ID: 28357782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey.
    Karakılıç Özturan E; Öztürk AP; Baş F; Erdoğdu AB; Kaptan S; Kardelen Al AD; Poyrazoğlu Ş; Yıldız M; Direk N; Yüksel Ş; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):276-284. PubMed ID: 36987788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP; Madison CM; Milne NM
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural Correlates of Psychosis and Gender Dysphoria in an Adult Male.
    Schwarz K; Fontanari AM; Mueller A; Soll B; da Silva DC; Salvador J; Zucker KJ; Schneider MA; Lobato MI
    Arch Sex Behav; 2016 Apr; 45(3):761-5. PubMed ID: 26597648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sex hormone administration changes pain in transsexual women and men.
    Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
    Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctive features of female-to-male transsexualism and prevalence of gender identity disorder in Japan.
    Baba T; Endo T; Ikeda K; Shimizu A; Honnma H; Ikeda H; Masumori N; Ohmura T; Kiya T; Fujimoto T; Koizumi M; Saito T
    J Sex Med; 2011 Jun; 8(6):1686-93. PubMed ID: 21477021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review.
    Costa R; Colizzi M
    Neuropsychiatr Dis Treat; 2016; 12():1953-66. PubMed ID: 27536118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexual Experiences in Transgender People: The Role of Desire for Gender-Confirming Interventions, Psychological Well-Being, and Body Satisfaction.
    Nikkelen SWC; Kreukels BPC
    J Sex Marital Ther; 2018 May; 44(4):370-381. PubMed ID: 29144853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons.
    Nota NM; Dekker MJHJ; Klaver M; Wiepjes CM; van Trotsenburg MA; Heijboer AC; den Heijer M
    Andrologia; 2017 Aug; 49(6):. PubMed ID: 27561756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity.
    Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM
    J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.